These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2005886

  • 1. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.
    Li YC, Ross J, Scheppler JA, Franza BR.
    Mol Cell Biol; 1991 Apr; 11(4):1883-93. PubMed ID: 2005886
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 4. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F, Shibata R, Ross EK, Brady JN, Martin MA.
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER, Alcamí J, López M, Soriano V, Holguín A.
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A.
    Thévenin C, Kim SJ, Rieckmann P, Fujiki H, Norcross MA, Sporn MB, Fauci AS, Kehrl JH.
    New Biol; 1990 Sep; 2(9):793-800. PubMed ID: 2177654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [Abstract] [Full Text] [Related]

  • 14. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 15. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM, Sweet MJ, Ross IL, Hume DA.
    J Virol; 1993 Dec 18; 67(12):6956-64. PubMed ID: 8230418
    [Abstract] [Full Text] [Related]

  • 16. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
    Mallardo M, Dragonetti E, Baldassarre F, Ambrosino C, Scala G, Quinto I.
    J Biol Chem; 1996 Aug 23; 271(34):20820-7. PubMed ID: 8702837
    [Abstract] [Full Text] [Related]

  • 17. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL, Kaddour H, Schlievert PM, Stapleton JT, Okeoma CM.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30111566
    [Abstract] [Full Text] [Related]

  • 18. Activation of human immunodeficiency virus gene expression by ultraviolet light in stably transfected human cells does not require the enhancer element.
    Valerie K, Singhal A, Kirkham JC, Laster WS, Rosenberg M.
    Biochemistry; 1995 Dec 05; 34(48):15760-7. PubMed ID: 7495807
    [Abstract] [Full Text] [Related]

  • 19. The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation.
    Lu YC, Touzjian N, Stenzel M, Dorfman T, Sodroski JG, Haseltine WA.
    J Acquir Immune Defic Syndr (1988); 1991 Dec 05; 4(2):173-7. PubMed ID: 1987353
    [Abstract] [Full Text] [Related]

  • 20. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.
    Demarchi F, D'Agaro P, Falaschi A, Giacca M.
    J Virol; 1993 Dec 05; 67(12):7450-60. PubMed ID: 8230466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.